Multicenter Phase I/II Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction
Phase of Trial: Phase I/II
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 19 Jan 2018 Planned End Date changed from 1 Oct 2018 to 1 Oct 2019.
- 19 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
- 20 Oct 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.